학술논문

Normal ex vivo mesenchymal stem cell function combined with abnormal immune profiles sets the stage for informative cell therapy trials in idiopathic pulmonary fibrosis patients
Document Type
Article
Source
In: Stem Cell Research and Therapy. (Stem Cell Research and Therapy, December 2022, 13(1))
Subject
Language
English
ISSN
17576512